As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Steakholder Foods Ltd. The largest reported stake is Gefen Capital Investments, LP's, at 20.9%. 3 filings are on record since August 14, 2025 (Schedule 13D, November 10, 2025).
Who owns Steakholder Foods Ltd.?
Sell to companies like Steakholder Foods Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lee Keng Jie · Sole voting: 72,583 · Shared voting: 0 · Sole dispositive: 72,583 · Shared dispositive: 0 · SCHEDULE 13D, 2026-10-07
- · Holder: Gefen Capital Investments, LP · Percent: 20.9% · SCHEDULE 13D
- · Holder: Armistice Capital, LLC · Percent: 4.99% · SCHEDULE 13G/A
Steakholder Foods Ltd. has 3 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of american depositary shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Gefen Capital Investments, LP | 20.9% | 297,081 | SCHEDULE 13D, 2025-11-10 | 2025-11-03 |
| 6.5% | 72,583 | SCHEDULE 13D, 2026-10-07 | 2026-10-01 | |
| Armistice Capital, LLC | 4.99% | 106,596 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
Holding shares or following this stake? See who's behind Steakholder Foods Ltd. and the warning signs.
Free to see. No signup.
Keep reading
More on Steakholder Foods Ltd. and the records around it.
Steakholder Foods Ltd. elsewhere on the record
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch Steakholder Foods Ltd.
Get an email when Steakholder Foods Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Steakholder Foods Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Steakholder Foods Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Steakholder Foods Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Lee Keng Jie | 72,583 | 0 | 72,583 | 0 | SCHEDULE 13D, 2026-10-07 |
The latest filing identifies Steakholder Foods Ltd. by CUSIP 85805R203 and gives its principal executive office as 22 EINSTEIN ST., NESS ZIONA (SCHEDULE 13D, 2026-10-07).
Purpose of Transaction (Item 4)
Gefen Capital Investments, LP
The information set forth in Items 3 and 6 of this Schedule 13D is incorporated by reference in its entirety into this Item 4. The Reporting Person holds all securities of the Issuer for investment purposes only. The ADSs beneficially owned by the Reporting Persons were purchased in a series of investment transactions, as follows: Private Placement On June 10, 2025, Gefen LP purchased 124,286 American Depositary Shares, each representing 500 ordinary shares of the Company, no par value of the Issuer (15,536 ADSs on a post-adjustment basis changing the current ratio from one ADS representing 500 ordinary shares to a new ratio of one ADS representing 4,000 ordinary shares, effective on September 10, 2025), at an offering price of $7.00 per ADS, totaling $870,000, to be used for the funding of Twine's operations pursuant to the Twine convertible loan agreement described below. Twine is an Israeli company. When the private placement was signed and closed, Gefen LP was a major shareholder of Twine. The Company agreed to file a registration statement, providing for the resale of the ADSs, per the terms of the agreement. Gefen LP funded this transaction through funds raised from its limited partners. D.B.W. Convertible Loan Agreement On June 5, 2025, D.B.W. Holdings (2005) Ltd. ("DBW"), an Israeli company wholly owned by Mr. David Wiessman which may be deemed a beneficial owner of Gefen LP, entered into a convertible loan agreement with the Issuer, pursuant to which DBW …The first part of Item 4 of the SCHEDULE 13D filed 2025-11-10; the filing has the rest
Lee Keng Jie
The reporting person acquired the 72,583 ADSs of issuer reported herein for investment purposes. Based on the reporting person's belief that the securities represented an attractive investment opportunity. The reporting person intends to review their investment on a continuing basis. Depending on various factors, including the issuer business, financial condition, and stock price, as well as general market and economic conditions, the reporting person may from time to time purchase additional ADSs or ordinary shares, or dispose of some or all of their holdings in the open market or in private transactions. Except as set forth above, the reporting person does not have any current plans or proposal that relate to or would result in any of the actions or transactions described in subparagraphs (a) through (j) of item 4 of schedule 13dItem 4 of the SCHEDULE 13D filed 2026-10-07
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2025-11-10 | Gefen Capital Investments, LP | 20.9% | SCHEDULE 13D |
| 2026-10-07 | Lee Keng Jie | 6.5% | SCHEDULE 13D |
Questions about who owns Steakholder Foods Ltd.
Who owns Steakholder Foods Ltd.?
On this page, 2 holders' latest ownership filings report 5% or more of Steakholder Foods Ltd.: Gefen Capital Investments, LP (20.9%, Schedule 13D, filed 2025-11-10) and Lee Keng Jie (6.5%, Schedule 13D, filed 2026-10-07).
Who are the largest shareholders of Steakholder Foods Ltd.?
By the share each holder's latest filing reports, the largest holders of Steakholder Foods Ltd. on this page are Gefen Capital Investments, LP (20.9%) and Lee Keng Jie (6.5%).
When did Gefen Capital Investments, LP buy into Steakholder Foods Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Gefen Capital Investments, LP on this page is the Schedule 13D, filed 2025-11-10, reporting 20.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Steakholder Foods Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.